This $2,997,922 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at Florida State University (FSU) to develop rapid, non-invasive brain stimulation treatments for post-traumatic stress disorder (PTSD). The award, which runs from September 30, 2024 to September 29, 2028, will enable FSU's Sponsored Research Administration division to conduct cutting-edge scientific studies to advance...
The federal Project Grant award of $5,954,349.00, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability treatment for combat veterans and service members with persistent post-concussion symptoms. The primary awardee, Virginia Commonwealth University, will collaborate with sub-awardees Palo Alto Veterans Institute For Research and Richmond Institute For Veterans...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
This federal Project Grant award, valued at $860,998.00 and issued by the Defense Health Agency, supports research under the Military Medical Research and Development (CFDA 12.420) program. The grant funds the University of California, San Francisco to conduct advanced research on the "Neurophysiology of Post-Traumatic Epilepsy: Unraveling Epileptogenesis Signals Biomarkers" over a 3-year period from April 1, 2025 to March 31, 2028. This research aims to transform healthcare for...
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
This $4,208,345.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a hybrid 1 effectiveness-implementation trial of partner-assisted prolonged exposure for post-traumatic stress disorder (PTSD). The awardee, the Regents of the University of Minnesota, will leverage its expertise in medical research to conduct this investigation at the University of Minnesota in Minneapolis, MN. The award period runs from...
This federal Project Grant award, valued at $707,436.00 and provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research at the Albert Einstein College of Medicine to investigate biomarker signatures related to post-traumatic epileptogenesis (PTEGENESIS) and treatments. The project has an award date of May 1, 2025 and an ultimate completion date of April 30, 2027. Additionally, the award includes a sub-grant...
The University of Arizona was awarded a $745,766.00 Project Grant under the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a randomized clinical trial on the use of psychiatric service dogs and prolonged exposure therapy for PTSD in military-connected populations. The award has a performance period from September 30, 2024 to September 28, 2025. As a subrecipient, the Lowcountry Center For Veterans Research will provide research support...
This federal Project Grant award of $183,258 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports longitudinal monitoring of cognitive changes in older veterans using telehealth computerized neuropsychological assessment. The award was made to East Bay Institute for Research & Education Inc., a non-profit organization focused on medical research, particularly in the domain of veteran health and neurological studies. The project,...
The federal Project Grant award in the amount of $1,607,403.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the East Bay Institute for Research & Education Inc., a non-profit organization located in Mather, California. The grant supports a longitudinal study to monitor cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The research project aims to generate...